Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Sex Transm Dis. 2017 Sep;44(9):551–556. doi: 10.1097/OLQ.0000000000000644

Table 1.

Differentiating the two serovars of Chlamydia using an in-house multiplex real-time PCR (first nine weeks of the study); serovar E was inoculated in 7 animals (STI arm) at week 1 followed by inoculation of serovar LGV-L2 at week 4. The first SHIV163p3 challenge (red arrow) was in week 5; at week 8, both serovars were inoculated in the animals. Throughout the study, the animals received a boost of Chlamydia (both serovars) every 4 weeks, and up to 20 SHIV challenges two times a week (red arrows).

E LGV SHIV E+LGV
graphic file with name nihms870977u1.jpg graphic file with name nihms870977u2.jpg graphic file with name nihms870977u3.jpg

Animal # Week 1 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9
1 ND E E E E* M M E
2 ND E E M M M* M M
3 ND E N N N* E N E
4 ND E E M E N E E
5 ND E E E E E E E
6 ND E E M LGV E E E
7 ND E E E E N E E
*

=animal SHIV-infected;

ND=not determined; E=serovar E; LGV=serovar LGV-L2; M=mixed population; N=negative result (no Chlamydia detected). Animal #4 was infected after 14 SHIV challenges (this table shows data only up to 9 viral challenges).

HHS Vulnerability Disclosure